RTTNews | Mar 16, 2021 08:10AM EDT

08:09 Tuesday, March 16, 2021 (RTTNews) - Galmed Pharma Doses First Subject In First In Human Phase 1 Trial Of Amilo-5MER For Chronic Inflammatory Diseases

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved